Continue to site >
Trending ETFs

iShares Biotechnology ETF

etf
IBB
Dividend policy
Active
Price as of:
$170.32 -2.91 0%
primary theme
Health Care Sector Equity
IBB (ETF)

iShares Biotechnology ETF

Dividend policy
Active
Price as of:
$170.32 -2.91 0%
primary theme
Health Care Sector Equity
IBB (ETF)

iShares Biotechnology ETF

Dividend policy
Active
Price as of:
$170.32 -2.91 0%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$170.32

-

0.16%

$0.28

0.45%

Vitals

YTD Return

12.2%

1 yr return

27.3%

3 Yr Avg Return

12.4%

5 Yr Avg Return

13.2%

Net Assets

$11.3 B

Holdings in Top 10

50.2%

52 WEEK LOW AND HIGH

$173.23
$130.38
$176.21

Expenses

OPERATING FEES

Expense Ratio 0.45%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 34.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$170.32

-

0.16%

$0.28

0.45%

IBB - Profile

Distributions

  • YTD Total Return 12.4%
  • 3 Yr Annualized Total Return 12.4%
  • 5 Yr Annualized Total Return 13.2%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.24%
DIVIDENDS
  • Dividend Yield 0.2%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    iShares Biotechnology ETF
  • Fund Family Name
    iShares
  • Inception Date
    Feb 05, 2001
  • Shares Outstanding
    65400000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Greg Savage

Fund Description

The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.


IBB - Performance

Return Ranking - Trailing

Period IBB Return Category Return Low Category Return High Rank in Category (%)
YTD 12.2% -80.1% 38.8% 34.74%
1 Yr 27.3% -28.4% 92.6% 34.85%
3 Yr 12.4%* -0.3% 38.2% 74.32%
5 Yr 13.2%* 2.2% 38.6% 74.65%
10 Yr 18.5%* 9.4% 21.6% 25.20%

* Annualized

Return Ranking - Calendar

Period IBB Return Category Return Low Category Return High Rank in Category (%)
2020 25.7% -13.6% 178.2% 15.12%
2019 25.0% 3.8% 63.8% 23.45%
2018 -9.7% -49.7% 21.5% 68.61%
2017 -59.8% -59.8% 54.4% 100.00%
2016 -21.6% -36.6% 11.6% 82.03%

Total Return Ranking - Trailing

Period IBB Return Category Return Low Category Return High Rank in Category (%)
YTD 12.4% -79.8% 43.4% 35.21%
1 Yr 27.3% -30.4% 92.6% 27.15%
3 Yr 12.4%* -15.9% 38.2% 68.72%
5 Yr 13.2%* -7.4% 38.6% 60.69%
10 Yr 18.5%* 9.4% 21.6% 21.80%

* Annualized

Total Return Ranking - Calendar

Period IBB Return Category Return Low Category Return High Rank in Category (%)
2020 25.7% -13.6% 178.2% 15.12%
2019 25.0% 3.8% 63.8% 23.45%
2018 -9.7% -25.3% 22.2% 71.53%
2017 20.7% -10.8% 54.4% 53.33%
2016 -21.6% -36.6% 11.6% 88.28%

IBB - Holdings

Concentration Analysis

IBB Category Low Category High IBB % Rank
Net Assets 11.3 B 2.72 M 53.2 B 7.95%
Number of Holdings 275 11 503 2.97%
Net Assets in Top 10 5.66 B 2.18 K 21.1 B 3.81%
Weighting of Top 10 50.18% 10.1% 94.7% 16.95%

Top 10 Holdings

  1. Moderna Inc 9.28%
  2. Amgen Inc 6.93%
  3. Gilead Sciences Inc 6.57%
  4. Regeneron Pharmaceuticals Inc 6.51%
  5. Regeneron Pharmaceuticals Inc 6.51%
  6. Regeneron Pharmaceuticals Inc 6.51%
  7. Regeneron Pharmaceuticals Inc 6.51%
  8. Regeneron Pharmaceuticals Inc 6.51%
  9. Regeneron Pharmaceuticals Inc 6.51%
  10. Regeneron Pharmaceuticals Inc 6.51%

Asset Allocation

Weighting Return Low Return High IBB % Rank
Stocks
99.91% 83.68% 104.21% 36.02%
Cash
0.09% -0.65% 9.16% 55.51%
Preferred Stocks
0.00% 0.00% 5.83% 51.69%
Other
0.00% -26.05% 9.11% 57.20%
Convertible Bonds
0.00% 0.00% 0.06% 47.46%
Bonds
0.00% 0.00% 17.12% 50.00%

Stock Sector Breakdown

Weighting Return Low Return High IBB % Rank
Healthcare
99.83% 61.99% 100.00% 45.76%
Basic Materials
0.17% 0.00% 8.23% 23.73%
Utilities
0.00% 0.00% 0.98% 47.46%
Technology
0.00% 0.00% 19.13% 52.97%
Real Estate
0.00% 0.00% 6.19% 50.00%
Industrials
0.00% 0.00% 7.02% 51.27%
Financial Services
0.00% 0.00% 1.78% 63.56%
Energy
0.00% 0.00% 0.71% 47.46%
Communication Services
0.00% 0.00% 7.81% 50.00%
Consumer Defense
0.00% 0.00% 28.21% 52.12%
Consumer Cyclical
0.00% 0.00% 17.63% 50.85%

Stock Geographic Breakdown

Weighting Return Low Return High IBB % Rank
US
89.48% 57.23% 100.70% 40.25%
Non US
10.43% 0.00% 42.77% 51.27%

IBB - Expenses

Operational Fees

IBB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.45% 0.08% 2.91% 63.20%
Management Fee 0.45% 0.00% 1.25% 15.91%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

IBB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

IBB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

IBB Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 34.00% 0.00% 256.00% 27.54%

IBB - Distributions

Dividend Yield Analysis

IBB Category Low Category High IBB % Rank
Dividend Yield 0.16% 0.00% 2.44% 17.02%

Dividend Distribution Analysis

IBB Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Quarterly Annually

Net Income Ratio Analysis

IBB Category Low Category High IBB % Rank
Net Income Ratio 0.24% -2.54% 1.92% 34.10%

Capital Gain Distribution Analysis

IBB Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

IBB - Fund Manager Analysis

Managers

Greg Savage


Start Date

Tenure

Tenure Rank

Jan 01, 2008

13.67

13.7%

Greg Savage, Managing Director; has been associated with BlackRock Fund Advisors since 2009. Mr. Savage has been a senior portfolio manager for BFA and BTC since 2009. Prior to his employment with BFA and BTC, Mr. Savage was a senior portfolio manager from 2006 to 2009 for BGFA and BGI and a portfolio manager from 2001 to 2006 for BGFA and BGI.

Jennifer Hsui


Start Date

Tenure

Tenure Rank

Aug 01, 2012

9.09

9.1%

Jennifer Hsui, Managing Director & Portfolio Manager at BlackRock Investment Management LLC has been employed by BlackRock Fund Advisors as a senior portfolio manager since 2007. Prior to that, Ms. Hsui was a portfolio manager from 2006 to 2007 for BGFA. She was a research analyst for RBC Capital Markets from 2003 to 2006.

Alan Mason


Start Date

Tenure

Tenure Rank

Apr 15, 2016

5.38

5.4%

Alan Mason is a Managing Director of BlackRock Advisors, LLC since 2009. Previously, Mr. Mason was a Managing Director of Barclays Global Investors from 2008 to 2009 and a Principal from 1996 to 2008.

Amy Whitelaw


Start Date

Tenure

Tenure Rank

Aug 01, 2018

3.08

3.1%

Amy Whitelaw is Managing Director of BlackRock, Inc. since 2013 and was Director of the firm from 2009 to 2012. Ms. Whitelaw's service with the firm dates back to 1998, including her years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. Ms. Whitelaw served as Principal of BGI from 2000 to 2009. Previously Ms. Whitelaw worked in the Transition Services group as a transition manager and strategist, and was also an international equity trader on BGI’s trading desk.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 23.98 6.66 1.38